Literature DB >> 31024211

Immunotolerant Chronic Hepatitis B Infection: When Do I Treat?

Sunil Kumar1, Thazhath M Ramachandran1.   

Abstract

Entities:  

Year:  2018        PMID： 31024211      PMCID： PMC6476936          DOI： 10.1016/j.jceh.2018.06.001

Source DB:  PubMed          Journal:  J Clin Exp Hepatol        ISSN： 0973-6883


× No keyword cloud information.
  10 in total

1.  Clinical factors associated with liver stiffness in hepatitis B e antigen-positive chronic hepatitis B patients.

Authors:  Grace Lai-Hung Wong; Vincent Wai-Sun Wong; Paul Cheung-Lung Choi; Anthony Wing-Hung Chan; Angel Mei-Ling Chim; Karen Ka-Lam Yiu; Hoi-Yun Chan; Francis Ka-Leung Chan; Joseph Jao-Yao Sung; Henry Lik-Yuen Chan
Journal:  Clin Gastroenterol Hepatol       Date:  2008-10-30       Impact factor: 11.382

2.  Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance.

Authors:  Norah A Terrault; Anna S F Lok; Brian J McMahon; Kyong-Mi Chang; Jessica P Hwang; Maureen M Jonas; Robert S Brown; Natalie H Bzowej; John B Wong
Journal:  Hepatology       Date:  2018-04       Impact factor: 17.425

3.  High prevalence of significant histology in asymptomatic chronic hepatitis B patients with genotype C and high serum HBV DNA levels.

Authors:  J Y Park; Y N Park; D Y Kim; Y H Paik; K S Lee; B S Moon; K-H Han; C Y Chon; S H Ahn
Journal:  J Viral Hepat       Date:  2008-06-28       Impact factor: 3.728

4.  Immune-tolerant Chronic Hepatitis B Infection-Is the Liver Really Tolerating?

Authors:  Sandeep Satsangi
Journal:  J Clin Exp Hepatol       Date:  2018-03-30

5.  High risk of hepatocellular carcinoma and death in patients with immune-tolerant-phase chronic hepatitis B.

Authors:  Gi-Ae Kim; Young-Suk Lim; Seungbong Han; Jonggi Choi; Ju Hyun Shim; Kang Mo Kim; Han Chu Lee; Yung Sang Lee
Journal:  Gut       Date:  2017-10-21       Impact factor: 23.059

Review 6.  HBV: Do I treat my immunotolerant patients?

Authors:  Jiannis Vlachogiannakos; George V Papatheodoridis
Journal:  Liver Int       Date:  2016-01       Impact factor: 5.828

7.  Effects of tenofovir disoproxil fumarate in hepatitis B e antigen-positive patients with normal levels of alanine aminotransferase and high levels of hepatitis B virus DNA.

Authors:  Henry L Y Chan; Chi Kuen Chan; Aric Josun Hui; Sing Chan; Fred Poordad; Ting-Tsung Chang; Philippe Mathurin; John F Flaherty; Lanjia Lin; Amy Corsa; Anuj Gaggar; G Mani Subramanian; John G McHutchison; George Lau; Sam Lee; Edward J Gane
Journal:  Gastroenterology       Date:  2014-01-23       Impact factor: 22.682

8.  Virologic and histologic features of chronic hepatitis B virus-infected asymptomatic patients with persistently normal ALT.

Authors:  Manoj Kumar; Shiv K Sarin; Syed Hissar; Chandana Pande; Puja Sakhuja; Barjesh Chander Sharma; Ranjit Chauhan; Sujoy Bose
Journal:  Gastroenterology       Date:  2008-02-29       Impact factor: 22.682

9.  Age-specific prognosis following spontaneous hepatitis B e antigen seroconversion in chronic hepatitis B.

Authors:  Yi-Cheng Chen; Chia-Ming Chu; Yun-Fan Liaw
Journal:  Hepatology       Date:  2010-02       Impact factor: 17.425

Review 10.  INASL Position Statements on Prevention, Diagnosis and Management of Hepatitis B Virus Infection in India: The Andaman Statements.

Authors:  Anil Arora; Shivaram P Singh; Ashish Kumar; Vivek A Saraswat; Rakesh Aggarwal; Manisha Bangar; Pradip Bhaumik; Harshad Devarbhavi; Radha K Dhiman; Vinod K Dixit; Ashish Goel; Bhabadev Goswami; Dharmesh Kapoor; Kaushal Madan; Jimmy Narayan; Sandeep Nijhawan; Gaurav Pandey; Ramesh R Rai; Manoj K Sahu; Neeraj Saraf; Thrivikrama Shenoy; Varghese Thomas; Manav Wadhawan
Journal:  J Clin Exp Hepatol       Date:  2017-12-16
  10 in total
  1 in total

Review 1.  CON: All Patients With Immune-Tolerated Hepatitis B Virus Do Not Need to Be Treated.

Authors:  Bashar M Attar
Journal:  Clin Liver Dis (Hoboken)       Date:  2020-02-25
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.